DxS Ltd, a molecular diagnostics company based Manchester, UK, has appointed Ron Long as chairman, replacing David Evans, who resigned.
Mr Long has been a board member since July 2008 and has long experience in the field of personalised medicine.
He remains a board member of Medivir AB, a Swedish drug development company, and as chairman of Procognia (Israel) Ltd, a specialist in glycobiology.
Copyright 2009 Evernow Publishing Ltd